| __timestamp | Amneal Pharmaceuticals, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 15635076 |
| Thursday, January 1, 2015 | 136870000 | 23943601 |
| Friday, January 1, 2016 | 204747000 | 23689111 |
| Sunday, January 1, 2017 | 191938000 | 41006114 |
| Monday, January 1, 2018 | 210451000 | 51379106 |
| Tuesday, January 1, 2019 | 202287000 | 32705593 |
| Wednesday, January 1, 2020 | 190585000 | 53274000 |
| Friday, January 1, 2021 | 209563000 | 85352000 |
| Saturday, January 1, 2022 | 200046000 | 51999000 |
| Sunday, January 1, 2023 | 167778000 | 59471000 |
Data in motion
In the competitive landscape of biopharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Summit Therapeutics Inc. and Amneal Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments.
Summit Therapeutics has shown a steady increase in R&D expenses, peaking in 2021 with a remarkable 450% increase from 2014. This surge underscores their aggressive pursuit of groundbreaking therapies, particularly in the field of antibiotics and rare diseases.
Conversely, Amneal Pharmaceuticals has maintained a more consistent R&D expenditure, with a modest 57% increase over the same period. Their strategy focuses on incremental innovation and expanding their generic drug portfolio.
This analysis highlights the diverse approaches within the industry, reflecting each company's unique vision and market strategy.
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Summit Therapeutics Inc.
R&D Spending Showdown: Alnylam Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and Amneal Pharmaceuticals, Inc.
Comparing Innovation Spending: Summit Therapeutics Inc. and Madrigal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and Rhythm Pharmaceuticals, Inc.
R&D Insights: How Summit Therapeutics Inc. and PTC Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and Travere Therapeutics, Inc.
Research and Development Investment: Halozyme Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Amneal Pharmaceuticals, Inc. vs Rhythm Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Amneal Pharmaceuticals, Inc. vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Amneal Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated